WORK Medical Technology (WOK) Equity Ratio (2023 - 2025)

WORK Medical Technology (WOK) reported Equity Ratio of 0.64 for Q3 2025, up 43.99% on a YoY basis from 0.44 in Q3 2024, and up 40.98% quarter-over-quarter from 0.45 in Q1 2025.

WORK Medical Technology (WOK) Equity Ratio (2023 - 2025) Analysis & Trends

WORK Medical Technology has reported Equity Ratio for 3 years, with the latest figure at 0.64 in Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio rose 43.99% year-over-year to 0.64; the trailing twelve-month figure through Sep 2025 stood at 0.64 (up 43.99% YoY), and the FY2025 full-year result was 0.64, up 43.99% from the prior year.
  • Equity Ratio for Q3 2025 stood at 0.64, up from 0.45 in the prior quarter.
  • The five-year high for Equity Ratio was 0.64 in Q3 2025, with the low at 0.37 in Q3 2023.
  • Historically, Equity Ratio has averaged 0.48 across 3 years, with a median of 0.45 in 2024.
  • Annual changes were most pronounced in 2024 — Equity Ratio gained 20.89% — and 2025, when it soared 43.99%.
  • WORK Medical Technology's Equity Ratio stood at 0.37 in 2023, then climbed by 20.89% to 0.44 in 2024, then surged by 43.99% to 0.64 in 2025.
  • The last three Equity Ratio figures came in at 0.64 (Q3 2025), 0.45 (Q1 2025), and 0.44 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.47
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.50
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.54
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.42
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.29
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.67
10 WORK Medical Technology - - - 0.64

Historic Data

Download Data
DateValue
Sep 30, 2025 0.64
Mar 31, 2025 0.45
Sep 30, 2024 0.44
Sep 30, 2023 0.37